IL6 and COVID-19: However, the reported levels of cytokines, including IL-6, in patients with COVID-19 were profoundly lower than those typically observed in non-COVID-19 ARDS cases and in sepsis, thus casting doubt on the role of cytokine storms in the progression to ARDS with COVID-19 [6].